1. Home
  2. PODD vs EC Comparison

PODD vs EC Comparison

Compare PODD & EC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • EC
  • Stock Information
  • Founded
  • PODD 2000
  • EC 1948
  • Country
  • PODD United States
  • EC Colombia
  • Employees
  • PODD N/A
  • EC N/A
  • Industry
  • PODD Medical/Dental Instruments
  • EC Oil & Gas Production
  • Sector
  • PODD Health Care
  • EC Energy
  • Exchange
  • PODD Nasdaq
  • EC Nasdaq
  • Market Cap
  • PODD 23.8B
  • EC 19.3B
  • IPO Year
  • PODD 2007
  • EC 2007
  • Fundamental
  • Price
  • PODD $317.83
  • EC $9.03
  • Analyst Decision
  • PODD Strong Buy
  • EC Hold
  • Analyst Count
  • PODD 18
  • EC 1
  • Target Price
  • PODD $337.06
  • EC $9.50
  • AVG Volume (30 Days)
  • PODD 662.8K
  • EC 1.8M
  • Earning Date
  • PODD 11-06-2025
  • EC 11-12-2025
  • Dividend Yield
  • PODD N/A
  • EC 10.99%
  • EPS Growth
  • PODD N/A
  • EC N/A
  • EPS
  • PODD 3.32
  • EC 0.07
  • Revenue
  • PODD $2,359,500,000.00
  • EC $31,941,645,477.00
  • Revenue This Year
  • PODD $29.13
  • EC N/A
  • Revenue Next Year
  • PODD $18.13
  • EC N/A
  • P/E Ratio
  • PODD $94.90
  • EC $121.30
  • Revenue Growth
  • PODD 26.00
  • EC N/A
  • 52 Week Low
  • PODD $225.37
  • EC $7.21
  • 52 Week High
  • PODD $353.50
  • EC $11.05
  • Technical
  • Relative Strength Index (RSI)
  • PODD 40.26
  • EC 49.65
  • Support Level
  • PODD $306.03
  • EC $9.02
  • Resistance Level
  • PODD $315.44
  • EC $9.33
  • Average True Range (ATR)
  • PODD 8.58
  • EC 0.17
  • MACD
  • PODD -1.93
  • EC -0.03
  • Stochastic Oscillator
  • PODD 45.94
  • EC 36.14

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About EC Ecopetrol S.A.

Ecopetrol SA is engaged in commercial and industrial activities related to the exploration, exploitation, refining, transportation, storage, distribution, and marketing of hydrocarbons, their derivatives, and products, as well as the electric power transmission services, design, development, construction, operation, and maintenance of road and energy infrastructure projects and the provision of information technology and telecommunications services. The operations of the company are performed through four business segments: Exploration and Production, Transport and Logistics, Refining and Petrochemical, and Electric Power Transmission and Toll Roads Concessions. The majority of the company's revenue is generated from the Refining and Petrochemical segment.

Share on Social Networks: